DSW Ventures leads £500k investment into Newcastle-based biotech InvenireX

DSW Ventures leads £500k investment into Newcastle-based biotech InvenireX

InvenireX, a Newcastle-based biotech company that aims to disrupt the market for PCR laboratory tests, has raised £500,000 in funding from DSW Ventures and XTX Ventures. InvenireX’s platform, which incorporates AI and programmable DNA, or ‘nanites’, enables scientists to rapidly…
DSW Ventures Investor Report – September 2023

DSW Ventures Investor Report – September 2023

The following is the manager report for the six months to September 2023 provided to investors in DSW Ventures portfolio companies. Please email investors@dsw.vc for further information. Overview and Market Conditions In terms of quoted markets, the broader technology market has…